Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

Bullboard (TSX:OPS)

View:
Post by bossuon Aug 30, 2022 1:09pm

5 year chart and where OPS is heading...

See the chart: And soon to top the $ 3,60 mark when the FDA  put the stamp APPROVED in the near futur ! Cannot be a clearer view 
Comment by Possibleidiot01on Aug 29, 2022 6:53pm

RE:RE:RE:Regarding the 2 questions of the FDA

I wouldn't mind seeing it as well . PI
Post by bossuon Aug 29, 2022 2:45pm

Opsens Inc. will received .....approval soon !

And the Market is taking note. and big expectation on a positive result from the FDA Scheduling : Health Canada File April 22 2022 Announcement Opsens Inc. has received Health Canada approval for the ...more  
Comment by bossuon Aug 29, 2022 1:38pm

RE:RE:RE:RE:RE:Regarding the 2 questions of the FDA

Quite an elaborate explanation. Plain and simple :my understading is that the back and forth ''questions and anwers'' is complete and at on point the FDA has a final delay to ...more  
Comment by ivebeenthereon Aug 29, 2022 11:49am

RE:RE:RE:RE:RE:Regarding the 2 questions of the FDA

When one ask for FDA approval its certain there is going to be questions to answer to in timely manner.I dont think that saying to someone that they answered  those two questions is privilege ...more  
Comment by CriticalCareon Aug 29, 2022 11:02am

RE:RE:RE:RE:Regarding the 2 questions of the FDA

Hi all, Interesting and worrying, that LL answers you with such precise information without disclosing this publicly. This is privilege information, The FDA 510(k)  process is very clear and ...more  
Comment by Dogsbreakfast4Uon Aug 27, 2022 8:13pm

RE:RE:RE:Regarding the 2 questions of the FDA

Thanks for the email chain between you and LL
Comment by ivebeenthereon Aug 27, 2022 11:06am

RE:RE:Regarding the 2 questions of the FDA

Send me your email address by private message ill be glad to transfer the message i got from  Mr Laflamme.
Comment by Dogsbreakfast4Uon Aug 27, 2022 8:47am

RE:Regarding the 2 questions of the FDA

  I am surprised the CEO would have shared this with you directly in an email within 24 hours without the investors relations staff getting involved. 
Comment by ddogoldon Aug 26, 2022 6:59pm

RE:Regarding the 2 questions of the FDA

Thanks for the update . Excellent news . Might explain the steady price appreciation and volume uptick . In Louis we trust . GLTA 
Post by ivebeenthereon Aug 26, 2022 6:48pm

Regarding the 2 questions of the FDA

After reading the questions on this site of different investors about  not knowing if answers were sent to the FDA. So yesterday afternoon i decided to send an email To Mister Louis Laflamme ...more  
Post by ivebeenthereon Aug 26, 2022 2:57pm

No Worries

On the CNBC app if you search for Opsens one of the good information they give is that 21% of the company is owned by institutional  invesment firms. In brief : The pros , those who have a better ...more  
Post by GoldenArmon Aug 26, 2022 2:55pm

Undervalued and trend

I think there is a cautious approach to this stock right now. With a 3yr time horizon to $100M. The stock is going to move up slowly unit the FDA news is announced. After we could see a pull back from ...more  
Comment by bossuon Aug 25, 2022 4:18pm

RE:RE:OPS going forward...

At this time the CEO did not mentioned if or when the last review was submited to the FDA ,  This an important date and OPS was expecting to have an answer in 60 days from that date.
Comment by ddogoldon Aug 25, 2022 4:12pm

RE:RE:OPS going forward...

Exactly so . In the meantime we slowly and steadily move up as people don't want to miss out . 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities